The Neuroregeneration Research Institute, founded in 1989 and led by Ole Isacson, Dr Med Sci, is accelerating the treatment of Parkinson's disease and other degenerative brain disorders. Our novel research team has a keen focus on improving individuals' lives. Our work has been the basis for numerous innovations that are creating hope for patients and their families.
We work to move the field forward by approaching new treatments using novel findings in the modeling of synaptic and neuroplasticity responses. This effort includes new basic neuroscience models for neurodegenerative diseases, such as Parkinson's disease, as well as cognitive models for aging research and neuropsychiatrically linked diseases.
Over the past two decades, our discoveries have significantly advanced our knowledge to the point that we are currently exploring viable therapies aimed at both protecting vulnerable neurons and replacing those destroyed by disease.
In addition, we coordinate with other training programs within psychiatry, neurology, neuroregeneration, stem cell biology, and regenerative medicine within the Boston region and internationally.